InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Kelly Scott A., Président. Director active across 1 companies, notably CytoDyn Inc.. Aggregated, 4 disclosures have been logged. The latest transaction was filed on 15 June 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations4 total
014,423 shares0
Common Stock
SEC:0001104659-22-073001:0·
015,592 shares0
Common Stock
SEC:0001104659-22-069307:0·
040,661 shares0
Common stock
SEC:0000899243-21-032395·
040,661 shares0
Common stock
SEC:0000899243-21-032395:0·
4 of 4 declarations
About Kelly Scott A.
Scott A. Kelly is the Chairman and Chief Medical Officer at CytoDyn Inc. He leads the company and oversees medical initiatives. Scott plays a key role in developing new treatments and achieving the company's objectives.
